Detalhe da pesquisa
1.
Comments on "Real-world re-treatment outcomes of direct-acting antiviral therapy failure in patients with chronic hepatitis C".
J Med Virol
; 94(2): 436-438, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34499359
2.
Therapeutic management of chronic hepatitis B in clinical practice: a region-wide survey.
J Clin Gastroenterol
; 49(3): 228-34, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24583753
3.
Genetic polymorphisms of IL28b gene as predictors of response to dual therapy in genotypes 1 and 4-HCV and HIV/HCV-infected patients.
New Microbiol
; 38(4): 499-509, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26485009
4.
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy.
Sci Rep
; 8(1): 8988, 2018 06 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29895871
5.
Effectiveness of first-generation HCV protease inhibitors: does HIV coinfection still play a role?
Eur J Gastroenterol Hepatol
; 28(1): 37-41, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26460621
6.
Epidemiological and clinical features of hepatitis delta in HBsAg-positive patients by HIV status.
Antivir Ther
; 20(2): 193-7, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-24963642